· Dr. Douglas Henley, American Academy of Family Physicians (AAFP), Executive Vice President and Chief Executive Officer. Dr. Henley works with the AAFP Board of Directors on the mission, strategy and vision of the organization and provides representation to others from the medical, public, and private
sectors.
· Dr. Michael K Magill, The Department of Family and Preventive Medicine, University of Utah School of Medicine, Past President, Association of Departments of Family Medicine. For 13 years he has held leadership roles in the University's Community Clinics, in which he leads transformation of primary care delivery under a model of Patient Centered Medical Homes known as Care by DesignTM.
· Dr. Steven Shapiro, University of Pittsburgh School of Medicine, Chief Medical & Scientific Officer. Dr. Shapiro's primary focus
is working with his colleagues across UPMC and the School of Medicine to develop improved models of clinical care based upon "good science" and "smart technology."

Dr. David R. Spriggs, Head, Division of Solid Tumor Oncology; Vice Chair Experimental Therapeutics, Department of Medicine,
Winthrop Rockefeller Chair of Medical Oncology. Memorial Sloan-Kettering Cancer Center. Dr. Spriggs leads Memorial Sloan-Kettering's program in early drug development, testing new, targeted drugs in clinical trials. He leads a research
laboratory examining the biology and novel drug treatment of ovarian cancer and how genes can affect the development of tumors. In his practice as a medical oncologist he takes care of patients with gynecological malignancies. He is an Associate Editor for the Journal Clinical Oncology, for Gynecologic Cancers.

Watson represents a new class of industry-specific analytical solutions and decision support systems that use deep content analysis and evidence-based reasoning and natural language processing. By accurately extracting medical facts and quickly understanding relationships buried in large volumes of data, such as electronic medical records, family medical
history, and the latest clinical research, the technology can help accelerate and improve clinical decisions, reduce operational waste, and
enhance patient outcomes.

"Watson represents a technology breakthrough that can help physicians improve patient outcomes," said Dr. Herbert Chase, a professor of clinical
medicine at Columbia University. "As IBM focuses its efforts on key areas including oncology, cardiology and other chronic diseases, the advisory board will be integral to helping align the business strategy to the specific needs of the industry."

More HCB News